SSR180711 hydrochloride
Code | Size | Price |
---|
TAR-T28856-100mg | 100mg | Enquire | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T28856-50mg | 50mg | Enquire | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Images
Documents
Further Information
Bioactivity:
SSR-180711A is a potent and selective partial agonist for Alpha7 nicotinic acetylcholine.
CAS:
446031-79-4
Formula:
C14H18BrClN2O2
Molecular Weight:
361.66
Purity:
0.98
SMILES:
Cl.Brc1ccc(OC(=O)N2CCN3CCC2CC3)cc1
References
1. Alterations in Cholinergic Pathways and Therapeutic Strategies Targeting Cholinergic System after Traumatic Brain Injury Samuel S. Shin, C. Edward Dixon J Neurotrauma. 2015 Oct 1; 32(19): 1429?1440. doi: 10.1089/neu.2014.3445 PMCID: PMC4842943
2. Targeting ?7 nicotinic acetylcholine receptors: a future potential for neuroprotection from traumatic brain injury Samuel S. Shin, C. Edward Dixon Neural Regen Res. 2015 Oct; 10(10): 1552?1554. doi: 10.4103/1673-5374.165309 PMCID: PMC4660732